ArticleEndometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator
Under an Elsevier user license
open archive
endometrium
CDB-4124
progesterone receptor modulator
histopathology
Cited by (0)
Supplementary information The online version of this article (doi:10.1038/modpathol.2008.204) contains supplementary material, which is available to authorized users.
Disclosure/conflict of interest
The authors received compensation from Repros Therapeutics Inc. for planning the pathology evaluation and blinded review of histological materials, but were not paid for the production of this paper and had full and independent control over all analysis and interpretation of the data. The study was funded by Repros Therapeutics Inc.
Supplementary Information accompanies the paper on Modern Pathology website (http://www.nature.com/modpathol)
© 2009 United States & Canadian Academy of Pathology.